• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Immunoassay Market

    ID: MRFR/HC/48524-HCR
    200 Pages
    Garvit Vyas
    September 2025

    UK Immunoassay Market Research Report By Type (Enzyme-Linked Immunosorbent Assay, Radioimmunoassay, Fluorescent Immunoassay, Chemiluminescent Immunoassay, Western Blot), By Technology (Automated Immunoassay, Point of Care Immunoassay, Lateral Flow Assay), By Application (Clinical Diagnostics, Drug Development, Environmental Testing, Food Safety Testing) andBy End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, Academic Research Institutions)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Immunoassay Market Research Report — Global Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    UK Immunoassay Market Summary

    The United Kingdom UK Immunoassay market is projected to grow from 2500 USD Million in 2024 to 4500 USD Million by 2035, reflecting a robust CAGR of 5.49%.

    Key Market Trends & Highlights

    UK Immunoassay Key Trends and Highlights

    • The UK Immunoassay market is valued at 2500 USD Million in 2024.
    • By 2035, the market is expected to reach 4500 USD Million, indicating substantial growth.
    • The compound annual growth rate (CAGR) from 2025 to 2035 is estimated at 5.49%.
    • Growing adoption of advanced diagnostic technologies due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 2500 (USD Million)
    2035 Market Size 4500 (USD Million)
    CAGR (2025 - 2035) 5.49%

    Major Players

    BP (GB), HSBC Holdings (GB), Unilever (GB), Diageo (GB), GlaxoSmithKline (GB), British American Tobacco (GB), AstraZeneca (GB), Vodafone Group (GB), Barclays (GB)

    UK Immunoassay Market Trends

    The UK Immunoassay Market is witnessing significant trends driven by advancements in technology and increasing healthcare demands. A key market driver is the rise in chronic diseases and the need for rapid diagnostic testing. With an aging population, the prevalence of conditions such as diabetes and cardiovascular diseases is escalating, prompting healthcare providers to seek efficient testing methods. This urgency shapes the landscape of immunoassay development, with a growing focus on point-of-care testing to enhance patient outcomes and streamline laboratory workflows.

    Opportunities to be explored in the UK include the integration of artificial intelligence and machine learning into immunoassay systems. As regards the National Health Service of the UK, the innovations detailed above could increase the efficacy and speed of tests done while simultaneously decreasing the price. Within these boundaries, the possibilities of collaboration between public health agencies and private firms to further R&D in the area are tremendous.

    The UK has been reported to also shift towards personalized medicine, where immunoassays have started to play a critical role in custom making treatment plans for patients. The advanced diagnostic capabilities under development are supported by policy initiatives intended to increase the available healthcare services in the UK.

    Additionally, there is a growing emphasis on developing tests for infectious diseases, particularly following the COVID-19 pandemic, which has prompted renewed focus on rapid testing solutions. This evolving landscape indicates a positive growth trajectory for the UK immunoassay market, fueled by technological advancements and pressing healthcare needs.

    UK Immunoassay Market Drivers

    Market Segment Insights

    Immunoassay Market Type Insights

    The UK Immunoassay Market is experiencing notable growth, characterized by a diverse range of types that cater to various applications in diagnostics and research settings. Enzyme-Linked Immunosorbent Assay (ELISA) remains a cornerstone within this sector, recognized for its versatility in detecting proteins, hormones, and antibodies. This technique is frequently utilized due to its high sensitivity and specificity, allowing for precise measurement of biomolecules in various samples.

    Meanwhile, Radioimmunoassay (RIA), although less prominent today, was foundational in the development of immunoassay technology, particularly in the quantification of antigens or hormones in serum and plasma. Its historical importance contributes to the understanding of immunoassays despite modern preferences shifting towards non-radioactive alternatives.

    Fluorescent Immunoassay (FIA) represents an innovative approach that harnesses fluorescent labels, gaining traction for its ability to provide rapid and accurate results, making it crucial in clinical laboratories for diagnostic testing and research applications. The Chemiluminescent Immunoassay (CLIA) is also significant, offering higher sensitivity and wider dynamic range compared to traditional methods - an advantageous feature for detecting low-abundance analytes, and is growing in popularity in hospitals and diagnostic facilities.

    Lastly, the Western Blot, while traditionally seen as a confirmatory test, plays a pivotal role in research settings to analyze specific proteins and their expressions. This method solidifies its importance in the immunoassay landscape. Each of these types not only enhances the capabilities of the UK Immunoassay Market industry but also responds to a growing demand for accurate diagnostic tools that cater to various health conditions, ultimately driving market growth.

    The landscape is further enriched by advancements in technology and innovation, with a constant push towards more efficient and user-friendly methodologies in the lab environment. The differentiation and specialization within these various types reflect their unique roles in the advancement of diagnostic capabilities, thus contributing to the evolving landscape in the UK. The market statistics showcase an expansive range within the immunoassay segmentation, as diverse applications necessitate adaptable and precise detection techniques to address ongoing and emerging medical challenges.

    Immunoassay Market Technology Insights

    The Technology segment of the UK Immunoassay Market plays a crucial role in advancing diagnostic capabilities and enhancing patient care. Within this segment, the Automated Immunoassay platforms contribute to increased efficiency and high-throughput testing, which is increasingly vital in clinical laboratories.

    Point of Care Immunoassay technologies facilitate rapid and accurate testing at or near the site of patient care, which significantly improves the speed of diagnosis and treatment decisions. Lateral Flow Assays are widely recognized for their simplicity and ease of use, making them ideal for various applications, including home testing and emergency settings.

    The growth drivers in this segment include advancements in technology, increasing demand for rapid testing, and the rising prevalence of chronic diseases, which require regular monitoring. Additionally, the UK government has focused on enhancing healthcare detection methods, thereby creating a conducive environment for innovations in the immunoassay Technology sector.

    As healthcare continues to evolve, the integration of these technologies into standard practices offers considerable opportunities for growth and improvement within the UK Immunoassay Market industry.

    Immunoassay Market Application Insights

    The UK Immunoassay Market is characterized by diverse applications, significantly impacting sectors like Clinical Diagnostics, Drug Development, Environmental Testing, and Food Safety Testing. Clinical Diagnostics serves a critical role in disease detection and management, facilitating timely decision-making in patient care.

    The Drug Development sector leverages immunoassays for crucial biomarker identification and therapeutic monitoring, ultimately accelerating drug approval timelines. Environmental Testing uses immunoassays to detect contaminants in water and soil, reflecting rising environmental concerns in the UK and adherence to regulations for public health safety.

    Food Safety Testing remains paramount, ensuring that food products are free from harmful substances, thereby protecting consumer health and complying with stringent regulations set by the UK government. The growth in these application areas is driven by technological advancements, increased healthcare expenditure, and a push for faster diagnostic procedures.

    However, challenges such as regulatory constraints and the need for continuous innovation persist. The UK's robust commitment to improving healthcare infrastructure and environmental standards creates promising opportunities for the immunoassay market, making it a crucial area of focus for ongoing development and investment.

    Overall, the application segmentation of the UK Immunoassay Market highlights its role in enhancing health outcomes, safety standards, and compliance across various sectors.

    Immunoassay Market End Use Insights

    The UK Immunoassay Market is witnessing substantial growth, particularly driven by its diverse End Use applications. Hospitals hold a significant share within this segment due to their increasing need for accurate diagnostics and patient monitoring.

    Diagnostic Laboratories play a critical role in facilitating the timely and precise testing required in various medical conditions, which enhances the demand for immunoassays. Pharmaceutical Companies also contribute prominently as they leverage immunoassays for innovative drug development and clinical trials, thus further propelling market growth.

    Academic Research Institutions are essential players in this landscape, focusing on pioneering research and studies that bolster the understanding and application of immunoassays in various fields. Together, these sectors not only drive the market but also underscore the importance of reliable diagnostic tools and their applications in improving health outcomes.

    With the growing emphasis on precision medicine and advancements in technology, the UK Immunoassay Market demonstrates a positive trajectory supported by strong demand across multiple End Use categories.

    Get more detailed insights about UK Immunoassay Market Research Report — Global Forecast till 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The UK Immunoassay Market is characterized by a competitive landscape where various players are vying for market share through innovation, advanced technologies, and a focus on customer needs. This market specializes in the use of immunoassay methods to detect and quantify biomolecules, which is crucial in diagnostics, research, and clinical applications.

    As healthcare systems evolve, the demand for rapid, accurate, and efficient diagnostic solutions drives firms to enhance their offerings and adapt to regulatory changes. Competitive insights reveal a market that is increasingly focused on personalized medicine and the integration of new technologies, such as point-of-care testing and automation, which optimizes laboratory workflows and improves patient outcomes.

    As a result, leading companies are strategically positioning themselves to enhance their presence and capabilities, emphasizing partnerships and collaborations to expand their product portfolios.

    Key Company Profiles

    Beckman Coulter

    In the UK Immunoassay Market, Beckman Coulter stands out as a prominent player with a well-established reputation for delivering innovative diagnostic solutions. The company capitalizes on its strengths in automated immunoassay systems, which provide high throughput and improved efficiency in laboratory settings.

    Beckman Coulter's advanced technologies facilitate a broad range of assays, enhancing its market presence in both clinical diagnostics and research applications. Its commitment to quality assurance, along with a strong focus on customer service, further solidifies its position in the competitive landscape. The company actively engages in collaborations and strategic partnerships to expand its technological capabilities and maintain a competitive edge in the UK market.

    Quidel

    Quidel has established a significant foothold in the UK Immunoassay Market, focusing on rapid diagnostic tests and reliable assay solutions. The company is known for its key product offerings that include immunoassays for infectious diseases, women's health, and gastrointestinal diseases, enhancing the diagnostic processes within healthcare settings.

    Quidel’s innovative approach and responsiveness to market demands underscore its competitive strengths, which include a commitment to research and development that drives new product introductions. The company's strategic mergers and acquisitions have bolstered its market presence in the UK, enabling it to expand its technological portfolio and access new customer segments. Additionally, its emphasis on point-of-care testing solutions aligns with the growing needs of healthcare providers seeking timely diagnostics, making it a vital competitor in the region's immunoassay market landscape.

    Key Companies in the UK Immunoassay Market market include

    Industry Developments

    The UK Immunoassay Market has seen significant developments recently, reflecting its vital role in diagnostics and healthcare. Notably, in August 2023, Abbott Laboratories launched a new immunoassay platform designed to enhance the speed and accuracy of disease detection, which has garnered positive responses from healthcare professionals across the UK.

    Additionally, Roche Diagnostics is ramping up investments in its manufacturing capabilities within the UK, aiming to meet the growing demand for diagnostic testing. In terms of mergers and acquisitions, a major development occurred in July 2023, as Thermo Fisher Scientific announced its acquisition of an innovative diagnostics company that specializes in immunoassays, which will strengthen its market presence.

    The overall valuation of the market is experiencing growth, spurred by technological advancements and increased healthcare spending in the UK. Notably, in 2021, Becton Dickinson launched a range of rapid testing solutions ahead of the surge in demand caused by the COVID-19 pandemic, which significantly impacted the immunoassay landscape. Such movements indicate a dynamic market environment focused on enhancing diagnostic capabilities and responsiveness to healthcare needs.

    Market Segmentation

    Immunoassay Market Type Outlook

    • Enzyme-Linked Immunosorbent Assay
    • Radioimmunoassay
    • Fluorescent Immunoassay
    • Chemiluminescent Immunoassay
    • Western Blot

    Immunoassay Market End Use Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Pharmaceutical Companies
    • Academic Research Institutions

    Immunoassay Market Technology Outlook

    • Automated Immunoassay
    • Point of Care Immunoassay
    • Lateral Flow Assay

    Immunoassay Market Application Outlook

    • Clinical Diagnostics
    • Drug Development
    • Environmental Testing
    • Food Safety Testing

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.22(USD Billion)
    MARKET SIZE 2024 1.5(USD Billion)
    MARKET SIZE 2035 2.4(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.365% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Beckman Coulter, Quidel, PerkinElmer, Mayo Clinic Laboratories, Abbott Laboratories, Diasorin, Eisai, BioRad Laboratories, Ortho Clinical Diagnostics, Becton Dickinson, Siemens Healthineers, Roche Diagnostics, Fujirebio, Thermo Fisher Scientific, Agilent Technologies
    SEGMENTS COVERED Type, Technology, Application, End Use
    KEY MARKET OPPORTUNITIES Increased demand for quick diagnostics, Advancements in point-of-care testing, Growth in personalized medicine applications, Expansion of disease-specific tests, Rising focus on home testing solutions
    KEY MARKET DYNAMICS Technological advancements, Rising chronic disease prevalence, Regulatory compliance pressures, Increasing diagnostic accuracy demand, Growth of point-of-care testing
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    What is the overall market size of the UK Immunoassay Market in 2024?

    The UK Immunoassay Market is expected to be valued at 1.5 billion USD in 2024.

    What is the projected value of the UK Immunoassay Market by 2035?

    By 2035, the UK Immunoassay Market is projected to reach a value of 2.4 billion USD.

    What is the expected CAGR for the UK Immunoassay Market from 2025 to 2035?

    The expected CAGR for the UK Immunoassay Market from 2025 to 2035 is 4.365 percent.

    Which type of immunoassay is projected to have the highest market value by 2035?

    The Enzyme-Linked Immunosorbent Assay is projected to have the highest market value at 0.72 billion USD by 2035.

    What are the market values for Radioimmunoassay in 2024 and 2035?

    The market value for Radioimmunoassay is expected to be 0.3 billion USD in 2024 and 0.48 billion USD in 2035.

    Who are the key players in the UK Immunoassay Market?

    Major players in the UK Immunoassay Market include Beckman Coulter, Quidel, PerkinElmer, Abbott Laboratories, and Thermo Fisher Scientific.

    What is the expected market value for Fluorescent Immunoassay by 2035?

    The market value for Fluorescent Immunoassay is expected to reach 0.55 billion USD by 2035.

    How much is the Chemiluminescent Immunoassay market valued at in 2024?

    The Chemiluminescent Immunoassay market is valued at 0.25 billion USD in 2024.

    What are the expected market values for Western Blot in 2024 and 2035?

    Western Blot is estimated at 0.35 billion USD in 2024 and 0.55 billion USD by 2035.

    What challenges does the UK Immunoassay Market currently face?

    The UK Immunoassay Market faces challenges such as stringent regulations and competition among key players.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK Immunoassay Market, BY Type (USD Billion)
    45. Enzyme-Linked Immunosorbent Assay
    46. Radioimmunoassay
    47. Fluorescent Immunoassay
    48. Chemiluminescent Immunoassay
    49. Western Blot
    50. UK Immunoassay Market, BY Technology (USD Billion)
    51. Automated Immunoassay
    52. Point of Care Immunoassay
    53. Lateral Flow Assay
    54. UK Immunoassay Market, BY Application (USD Billion)
    55. Clinical Diagnostics
    56. Drug Development
    57. Environmental Testing
    58. Food Safety Testing
    59. UK Immunoassay Market, BY End Use (USD Billion)
    60. Hospitals
    61. Diagnostic Laboratories
    62. Pharmaceutical Companies
    63. Academic Research Institutions
    64. Competitive Landscape
    65. Overview
    66. Competitive Analysis
    67. Market share Analysis
    68. Major Growth Strategy in the Immunoassay Market
    69. Competitive Benchmarking
    70. Leading Players in Terms of Number of Developments in the Immunoassay Market
    71. Key developments and growth strategies
    72. New Product Launch/Service Deployment
    73. Merger & Acquisitions
    74. Joint Ventures
    75. Major Players Financial Matrix
    76. Sales and Operating Income
    77. Major Players R&D Expenditure. 2023
    78. Company Profiles
    79. Beckman Coulter
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Quidel
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. PerkinElmer
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Mayo Clinic Laboratories
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Abbott Laboratories
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Diasorin
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Eisai
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. BioRad Laboratories
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Ortho Clinical Diagnostics
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Becton Dickinson
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Siemens Healthineers
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Roche Diagnostics
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Fujirebio
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Thermo Fisher Scientific
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. Agilent Technologies
    164. Financial Overview
    165. Products Offered
    166. Key Developments
    167. SWOT Analysis
    168. Key Strategies
    169. References
    170. Related Reports
    171. UK Immunoassay Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    172. UK Immunoassay Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    173. UK Immunoassay Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    174. UK Immunoassay Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
    175. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    176. ACQUISITION/PARTNERSHIP
    177. MARKET SYNOPSIS
    178. UK IMMUNOASSAY MARKET ANALYSIS BY TYPE
    179. UK IMMUNOASSAY MARKET ANALYSIS BY TECHNOLOGY
    180. UK IMMUNOASSAY MARKET ANALYSIS BY APPLICATION
    181. UK IMMUNOASSAY MARKET ANALYSIS BY END USE
    182. KEY BUYING CRITERIA OF IMMUNOASSAY MARKET
    183. RESEARCH PROCESS OF MRFR
    184. DRO ANALYSIS OF IMMUNOASSAY MARKET
    185. DRIVERS IMPACT ANALYSIS: IMMUNOASSAY MARKET
    186. RESTRAINTS IMPACT ANALYSIS: IMMUNOASSAY MARKET
    187. SUPPLY / VALUE CHAIN: IMMUNOASSAY MARKET
    188. IMMUNOASSAY MARKET, BY TYPE, 2025 (% SHARE)
    189. IMMUNOASSAY MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    190. IMMUNOASSAY MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    191. IMMUNOASSAY MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    192. IMMUNOASSAY MARKET, BY APPLICATION, 2025 (% SHARE)
    193. IMMUNOASSAY MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    194. IMMUNOASSAY MARKET, BY END USE, 2025 (% SHARE)
    195. IMMUNOASSAY MARKET, BY END USE, 2019 TO 2035 (USD Billions)
    196. BENCHMARKING OF MAJOR COMPETITORS

    UK Immunoassay Market Segmentation

    • Immunoassay Market By Type (USD Billion, 2019-2035)

      • Enzyme-Linked Immunosorbent Assay
      • Radioimmunoassay
      • Fluorescent Immunoassay
      • Chemiluminescent Immunoassay
      • Western Blot

    • Immunoassay Market By Technology (USD Billion, 2019-2035)

      • Automated Immunoassay
      • Point of Care Immunoassay
      • Lateral Flow Assay

    • Immunoassay Market By Application (USD Billion, 2019-2035)

      • Clinical Diagnostics
      • Drug Development
      • Environmental Testing
      • Food Safety Testing

    • Immunoassay Market By End Use (USD Billion, 2019-2035)

      • Hospitals
      • Diagnostic Laboratories
      • Pharmaceutical Companies
      • Academic Research Institutions
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027